Toggle Mobile Navigation

Brochure Available: 7th Drug Formulation, Solubility & Bioavailability Summit

When over 80% of APIs in development are poorly water-soluble, drug companies must increasingly rely on new formulation and delivery strategies to maximize bioavailability. ExL Events is proud to announce its 7th Drug Formulation, Solubility & Bioavailability Summit, taking place March 26–28, 2018 in Boston, MA.

We invite you to download the brochure for the leading industry event geared toward helping you identify the precise thresholds when enabled formulations are necessary, as well as determining which methods to use and how to predict and gauge their successes.


  • Insight on the prospects of virtual or ultra-rapid drug development
  • Detailed strategies on how to develop, deploy, and gauge the performance of the next generation of formulation modeling
  • Methods to accelerate and anticipate long-term stability answers
  • Techniques to shorten the bridge between preclinical and clinical data gathering
  • Plus: a full-day, intensive seminar on Advances in Drug Delivery, featuring oral biologics, depot microparticles, long-acting injectables, targeted tissue delivery and much more!


  • Joachim HoechelHead, Clinical PharmacologyBAYER
  • Rossitza AlargovaDirector, Formulations, INFINITY PHARMACEUTICALS
  • Fady IbrahimPrincipal Scientist, Biopharmaceutics, PFIZER
  • Robert SaklatvalaDirector, Basic Pharmaceutical Sciences, MERCK
  • Rakesh DixitVice President, R&D, Global Biologics Safety, MEDIMMUNE
  • … And More!

You can save $200 off the standard pricing if you register by Friday, February 9! To register, please call 866-207-6528 or click here.

posted in ExL Events News

live chat software